The replication-competent HIV-1 latent reservoir is primarily established near the time of therapy initiation

MAFFT Multiple Sequence Alignment Software Version 7: Improvements in Performance and Usability

Katoh, K., & Standley, D. M. (2013) · Molecular Biology and Evolution · doi:10.1093/molbev/mst010 · Cited by 46,209

MUSCLE: multiple sequence alignment with high accuracy and high throughput

Edgar, R. C. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh340 · Cited by 44,662

FastTree: Computing Large Minimum Evolution Trees with Profiles instead of a Distance Matrix

Price, M. N., Dehal, P. S., & Arkin, A. P. (2009) · Molecular Biology and Evolution · doi:10.1093/molbev/msp077 · Cited by 5,602

Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy

Finzi, D., Hermankova, M., Pierson, T., Carruth, L. M., Buck, C., Chaisson, R. E., Quinn, T. C., Chadwick, K., Margolick, J., Brookmeyer, R., et al. (1997) · Science · doi:10.1126/science.278.5341.1295 · Cited by 3,098

ETE 3: Reconstruction, Analysis, and Visualization of Phylogenomic Data

Huerta‐Cepas, J., Serra, F., & Bork, P. (2016) · Molecular Biology and Evolution · doi:10.1093/molbev/msw046 · Cited by 2,255

Recovery of replication-competent HIV despite prolonged suppression of plasma viremia

Wong, J. K., Hezareh, M., Günthard, H. F., Havlir, D. V., Ignacio, C. C., Spina, C. A., & Richman, D. D. (1997) · Science · doi:10.1126/science.278.5341.1291 · Cited by 2,186

Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection

Chun, T.-W., Carruth, L., Finzi, D., Shen, X., DiGiuseppe, J. A., Taylor, H., Hermankova, M., Chadwick, K., Margolick, J., Quinn, T. C., et al. (1997) · Nature · doi:10.1038/387183a0 · Cited by 2,050

Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy

Chun, T., Stuyver, L. J., Mizell, S. B., Ehler, L. A., Mican, J. A. M., Baseler, M., Lloyd, A. L., Nowak, M. A., & Fauci, A. S. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.13193 · Cited by 1,960

Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection

Keele, B. F., Giorgi, E. E., Salazar-Gonzalez, J. F., Decker, J. M., Pham, K. T., Salazar, M. G., Sun, C., Grayson, T. B., Wang, S., Li, H., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802203105 · Cited by 1,913

HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation

Chomont, N., Far, M. E., Ancuța, P., Trautmann, L., Procopio, F. A., Yassine‐Diab, B., Boucher, G., Boulassel, M., Ghattas, G., Brenchley, J. M., et al. (2009) · Nature Medicine · doi:10.1038/nm.1972 · Cited by 1,775

Research priorities for an HIV cure: International AIDS Society Global Scientific Strategy 2021

Deeks, S. G., Archin, N., Cannon, P., Collins, S., Jones, R. B., de Jong, M. A. W. P., Lambotte, O., Lamplough, R., Ndung’u, T., Sugarman, J., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01590-5 · Cited by 377

Systemic HIV and SIV latency reversal via non-canonical NF-κB signalling in vivo

Nixon, C. C., Mavigner, M., Sampey, G. C., Brooks, A. D., Spagnuolo, R. A., Irlbeck, D. M., Mattingly, C., Ho, P. T., Schoof, N., Cammon, C. G., et al. (2020) · Nature · doi:10.1038/s41586-020-1951-3 · Cited by 308

The Biology of the HIV-1 Latent Reservoir and Implications for Cure Strategies

Cohn, L. B., Chomont, N., & Deeks, S. G. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.03.014 · Cited by 296

HIV infection

Bekker, L., Beyrer, C., Mgodi, N. M., Lewin, S. R., Delany‐Moretlwe, S., Taiwo, B., Masters, M. C., & Lazarus, J. V. (2023) · Nature Reviews Disease Primers · doi:10.1038/s41572-023-00452-3 · Cited by 289

Curing HIV: Seeking to Target and Clear Persistent Infection

Margolis, D. M., Archin, N. M., Cohen, M. S., Eron, J. J., Ferrari, G., García, J. V., Gay, C. L., Goonetilleke, N. P., Joseph, S., Swanstrom, R. I., et al. (2020) · Cell · doi:10.1016/j.cell.2020.03.005 · Cited by 179

Early intervention with 3BNC117 and romidepsin at antiretroviral treatment initiation in people with HIV-1: a phase 1b/2a, randomized trial

Gunst, J. D., Pahus, M. H., Rosás-Umbert, M., Lu, I., Benfield, T., Nielsen, H. I., Johansen, I. S., Mohey, R., Østergaard, L. J., Klastrup, V., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-02023-7 · Cited by 143

The multifaceted nature of HIV latency

Dufour, C., Gantner, P., Fromentin, R., & Chomont, N. (2020) · Journal of Clinical Investigation · doi:10.1172/jci136227 · Cited by 104

In Vivo Dynamics of the Latent Reservoir for HIV-1: New Insights and Implications for Cure

Siliciano, J. D., & Siliciano, R. F. (2021) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-050520-112001 · Cited by 94

Fc-mediated effector function contributes to the in vivo antiviral effect of an HIV neutralizing antibody

Asokan, M., Dias, J., Liu, C., Maximova, A. A., Ernste, K., Pegu, A., McKee, K., Shi, W., Chen, X., Almasri, C. G., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2008236117 · Cited by 87

Autologous IgG antibodies block outgrowth of a substantial but variable fraction of viruses in the latent reservoir for HIV-1

Bertagnolli, L. N., Varriale, J., Sweet, S. E., Brockhurst, J., Simonetti, F. R., White, J., Beg, S. A., Lynn, K., Mounzer, K., Frank, I., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2020617117 · Cited by 84

Heightened resistance to host type 1 interferons characterizes HIV-1 at transmission and after antiretroviral therapy interruption

Gondim, M. V. P., Sherrill-Mix, S. A., Bibollet‐Ruche, F., Russell, R. M., Trimboli, S., Smith, A. G., Li, Y., Liu, W., Avitto, A. N., DeVoto, J. C., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abd8179 · Cited by 81

Longitudinal clonal dynamics of HIV-1 latent reservoirs measured by combination quadruplex polymerase chain reaction and sequencing

Cho, A., Gaebler, C., Olveira, T., Ramos, V., Saad, M., Lorenzi, J. C. C., Gazumyan, A., Moir, S. L., Caskey, M. F., Chun, T., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2117630119 · Cited by 77

The forces driving clonal expansion of the HIV-1 latent reservoir

Liu, R., Simonetti, F. R., & Ho, Y. (2020) · Virology Journal · doi:10.1186/s12985-019-1276-8 · Cited by 79

HIV persistence in subsets of CD4+ T cells: 50 shades of reservoirs

Fromentin, R., & Chomont, N. (2020) · Seminars in Immunology · doi:10.1016/j.smim.2020.101438 · Cited by 70

The multifaceted nature of HIV latency

Dufour, C., Gantner, P., Fromentin, R., & Chomont, N. (2021) · Journal of Clinical Investigation · doi:10.1172/jci151380 · Cited by 63

Insights Into Persistent HIV-1 Infection and Functional Cure: Novel Capabilities and Strategies

Ta, T. M., Malik, S., Anderson, E. M., Jones, A. D., Perchik, J., Freylikh, M., Sardo, L., Klase, Z. A., & Izumi, T. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.862270 · Cited by 61

The Glutamate System as a Crucial Regulator of CNS Toxicity and Survival of HIV Reservoirs

Górska, A. M., & Eugenín, E. A. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00261 · Cited by 57

Dynamics of HIV DNA reservoir seeding in a cohort of superinfected Kenyan women

Pankau, M. D., Reeves, D. B., Harkins, E., Ronen, K., Jaoko, W. G., Mandaliya, K. N., Graham, S. M., McClelland, R. S., Matsen, F. A., IV, Schiffer, J. T., et al. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1008286 · Cited by 53

HIV-1 variants are archived throughout infection and persist in the reservoir

Brooks, K., Jones, B. R., Dilernia, D. A., Wilkins, D. J., Claiborne, D. T., McInally, S., Gilmour, J. W., Kilembe, W., Joy, J. B., Allen, S. A., et al. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1008378 · Cited by 53

HIV-1 Proviral Transcription and Latency in the New Era

Shukla, A., Ramirez, N.-G. P., & D’Orso, I. (2020) · Viruses · doi:10.3390/v12050555 · Cited by 52

mTOR Overcomes Multiple Metabolic Restrictions to Enable HIV-1 Reverse Transcription and Intracellular Transport

Taylor, H. E., Calantone, N., Lichon, D., Hudson, H., Clerc, I., Campbell, E. M., & D’Aquila, R. T. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107810 · Cited by 48

Genotypic Resistance Testing of HIV-1 DNA in Peripheral Blood Mononuclear Cells

Chu, C., Armenia, D., Walworth, C., Santoro, M. M., & Shafer, R. W. (2022) · Clinical Microbiology Reviews · doi:10.1128/cmr.00052-22 · Cited by 48

Lessons for Understanding Central Nervous System HIV Reservoirs from the Last Gift Program

Riggs, P. K., Chaillon, A., Jiang, G., Letendre, S. L., Tang, Y., Taylor, J., Kaytes, A., Smith, D. M., Dubé, K., & Gianella, S. (2022) · Current HIV/AIDS Reports · doi:10.1007/s11904-022-00628-8 · Cited by 47

HIV-1 Latency and Viral Reservoirs: Existing Reversal Approaches and Potential Technologies, Targets, and Pathways Involved in HIV Latency Studies

Khanal, S., Schank, M., Gazzar, M. E., Moorman, J. P., & Yao, Z. Q. (2021) · Cells · doi:10.3390/cells10020475 · Cited by 47

HIV-1 Reservoir Persistence and Decay: Implications for Cure Strategies

Kreider, E. F., & Bar, K. J. (2022) · Current HIV/AIDS Reports · doi:10.1007/s11904-022-00604-2 · Cited by 46

Defective HIV-1 genomes and their potential impact on HIV pathogenesis

Kuniholm, J., Coote, C., & Henderson, A. J. (2022) · Retrovirology · doi:10.1186/s12977-022-00601-8 · Cited by 46

Phenotypic characterization of single CD4+ T cells harboring genetically intact and inducible HIV genomes

Dufour, C., Richard, C., Pardons, M., Massanella, M., Ackaoui, A., Murrell, B., Routy, B., Thomas, R., Routy, J., Fromentin, R., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36772-x · Cited by 47

CD8+ T cells promote HIV latency by remodeling CD4+ T cell metabolism to enhance their survival, quiescence, and stemness

Mutascio, S., Mota, T. M., Franchitti, L., Sharma, A., Willemse, A., Bergstresser, S. N., Wang, H., Statzu, M., Tharp, G. K., Weiler, J., et al. (2023) · Immunity · doi:10.1016/j.immuni.2023.03.010 · Cited by 44

Improved killing of HIV-infected cells using three neutralizing and non-neutralizing antibodies

Tuyishime, M., Garrido, C., Jha, S., Moeser, M., Mielke, D., LaBranche, C. C., Montefiori, D. C., Haynes, B. F., Joseph, S., Margolis, D. M., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci135557 · Cited by 39

Cells producing residual viremia during antiretroviral treatment appear to contribute to rebound viremia following interruption of treatment

Aamer, H., McClure, J., Ko, D. L., Maenza, J. R., Collier, A. C., Coombs, R. W., Mullins, J. I., & Frenkel, L. M. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1008791 · Cited by 39

An ordeal that does not heal: understanding barriers to a cure for HIV-1 infection

Lichterfeld, M. D., Gao, C., & Yu, X. G. (2022) · Trends in Immunology · doi:10.1016/j.it.2022.06.002 · Cited by 41

HIV persistence: silence or resistance?

Pasternak, A. O., & Berkhout, B. (2023) · Current Opinion in Virology · doi:10.1016/j.coviro.2023.101301 · Cited by 43

Clearance of HIV infection by selective elimination of host cells capable of producing HIV

Li, M., Liu, W., Bauch, T., Graviss, E. A., Arduino, R. C., Kimata, J. T., Chen, M., & Wang, J. (2020) · Nature Communications · doi:10.1038/s41467-020-17753-w · Cited by 38

GS-9822, a Preclinical LEDGIN Candidate, Displays a Block-and-Lock Phenotype in Cell Culture

Bruggemans, A., Vansant, G., Balakrishnan, M., Mitchell, M. L., Cai, R., Christ, F., & Debyser, Z. (2021) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02328-20 · Cited by 35

The HIV-1 latent reservoir is largely sensitive to circulating T cells

Warren, J. A., Zhou, S., Xu, Y., Moeser, M., MacMillan, D., Kirchherr, J., Sung, J., Roan, N. R., Adimora, A. A., Joseph, S., et al. (2020) · eLife · doi:10.7554/elife.57246 · Cited by 36

The Clonal Expansion Dynamics of the HIV-1 Reservoir: Mechanisms of Integration Site-Dependent Proliferation and HIV-1 Persistence

Yeh, Y.-H. J., Yang, K., Razmi, A., & Ho, Y. (2021) · Viruses · doi:10.3390/v13091858 · Cited by 35

A histone deacetylase network regulates epigenetic reprogramming and viral silencing in HIV-infected cells

Peterson, J. J., Lewis, C. A., Burgos, S. D., Ashokkumar, M., Xu, Y., Rowley, A. A., Clutton, G., Richardson, B., Zou, F., Simon, J. M., et al. (2023) · Cell chemical biology · doi:10.1016/j.chembiol.2023.11.009 · Cited by 35

IP-10 Promotes Latent HIV Infection in Resting Memory CD4+ T Cells via LIMK-Cofilin Pathway

Wang, Z., Yin, X., Ma, M., Ge, H., Lang, B., Sun, H., He, S., Fu, Y., Sun, Y., Yu, X., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.656663 · Cited by 31

Genetic Diversity, Compartmentalization, and Age of HIV Proviruses Persisting in CD4 + T Cell Subsets during Long-Term Combination Antiretroviral Therapy

Jones, B. R., Miller, R. L., Kinloch, N. N., Tsai, O., Rigsby, H., Sudderuddin, H., Shahid, A., Ganase, B., Brumme, C. J., Harris, M., et al. (2020) · Journal of Virology · doi:10.1128/jvi.01786-19 · Cited by 29

‘Rinse and Replace’: Boosting T Cell Turnover To Reduce HIV-1 Reservoirs

Grossman, Z., Singh, N. J., Simonetti, F. R., Lederman, M. M., Douek, D. C., Deeks, S. G., Kawabe, T., Bocharov, G. A., Meier‐Schellersheim, M., Alon, H., et al. (2020) · Trends in Immunology · doi:10.1016/j.it.2020.04.003 · Cited by 30

Targeted Chromatinization and Repression of HIV-1 Provirus Transcription with Repurposed CRISPR/Cas9

Olson, A., Basukala, B., Lee, S., Gagné, M., Wong, W. W., & Henderson, A. J. (2020) · Viruses · doi:10.3390/v12101154 · Cited by 29

Single-cell imaging shows that the transcriptional state of the HIV-1 provirus and its reactivation potential depend on the integration site

Janssens, J., De Wit, F., Parveen, N., & Debyser, Z. (2022) · mBio · doi:10.1128/mbio.00007-22 · Cited by 28

Plasma-Derived HIV-1 Virions Contain Considerable Levels of Defective Genomes

Fisher, K., Wang, X. Q., Lee, A., Morcilla, V., de Vries, A., Lee, E., Eden, J., Deeks, S. G., Kelleher, A. D., & Palmer, S. (2022) · Journal of Virology · doi:10.1128/jvi.02011-21 · Cited by 30

Rebound HIV-1 in cerebrospinal fluid after antiviral therapy interruption is mainly clonally amplified R5 T cell-tropic virus

Kincer, L. P., Joseph, S., Gilleece, M. M., Hauser, B. M., Sizemore, S., Zhou, S., Germanio, C. D., Zetterberg, H., Fuchs, D., Deeks, S. G., et al. (2023) · Nature Microbiology · doi:10.1038/s41564-022-01306-6 · Cited by 27

Antiretroviral therapy reveals triphasic decay of intact SIV genomes and persistence of ancestral variants

Fray, E. J., Wu, F., Simonetti, F. R., Zitzmann, C., Sambaturu, N., Molina-Parı́s, C., Bender, A. M., Liu, P.-T., Ventura, J. D., Wiseman, R. W., et al. (2023) · Cell Host & Microbe · doi:10.1016/j.chom.2023.01.016 · Cited by 29

Humanized Mice for Studies of HIV-1 Persistence and Elimination

Zhang, C., Zaman, L. A., Poluektova, L. Y., Gorantla, S., Gendelman, H. E., & Dash, P. K. (2023) · Pathogens · doi:10.3390/pathogens12070879 · Cited by 29

Rilpivirine-associated aggregation-induced emission enables cell-based nanoparticle tracking

Mukadam, I. Z., Machhi, J., Herskovitz, J., Hasan, M., Oleynikov, M. D., Blomberg, W. R., Svechkarev, D. A., Mohs, A. M., Zhou, Y., Dash, P. K., et al. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119669 · Cited by 27

Blocking Formation of the Stable HIV Reservoir: A New Perspective for HIV-1 Cure

Goonetilleke, N. P., Clutton, G., Swanstrom, R., & Joseph, S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01966 · Cited by 27

Immune-mediated strategies to solving the HIV reservoir problem

Kulpa, D. A., Paiardini, M., & Silvestri, G. (2025) · Nature reviews. Immunology · doi:10.1038/s41577-025-01136-7 · Cited by 30

Non-nucleoside reverse transcriptase inhibitor-based combination antiretroviral therapy is associated with lower cell-associated HIV RNA and DNA levels compared to protease inhibitor-based therapy

Pasternak, A. O., Vroom, J., Kootstra, N. A., Wit, F. W. N. M., de Bruin, M., Francesco, D. D., Bakker, M. E., Sabin, C. A., Winston, A., Prins, J. M., et al. (2021) · eLife · doi:10.7554/elife.68174 · Cited by 25

Differences in HIV Markers between Infected Individuals Treated with Different ART Regimens: Implications for the Persistence of Viral Reservoirs

Darcis, G., Berkhout, B., & Pasternak, A. O. (2020) · Viruses · doi:10.3390/v12050489 · Cited by 24

Fingolimod inhibits multiple stages of the HIV-1 life cycle

Resop, R. S., Fromentin, R., Newman, D., Rigsby, H., Dubrovsky, L., Bukrinsky, M., Chomont, N., & Bosque, A. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1008679 · Cited by 24

New insights into pathogenesis point to HIV-1 Tat as a key vaccine target

Ensoli, B., Moretti, S., Borsetti, A., Maggiorella, M. T., Buttò, S., Picconi, O., Tripiciano, A., Sgadari, C., Monini, P., & Cafaro, A. (2021) · Archives of Virology · doi:10.1007/s00705-021-05158-z · Cited by 24

Clonal Expansion of Infected CD4+ T Cells in People Living with HIV

Coffin, J. M., & Hughes, S. H. (2021) · Viruses · doi:10.3390/v13102078 · Cited by 26

Intragenic proviral elements support transcription of defective HIV-1 proviruses

Kuniholm, J., Armstrong, E. M. R., Bernabe, B., Coote, C., Berenson, A., Drinan, S. D., Olson, A., He, X., Lin, N., Bass, J. I. F., et al. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009982 · Cited by 25

Cognitive impairment in people living with HIV: mechanisms, controversies, and future perspectives

Moschopoulos, C. D., Alford, K. A., Antoniadou, A., & Vera, J. H. (2024) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2024.06.005 · Cited by 22

Broadly neutralizing antibodies combined with latency-reversing agents or immune modulators as strategy for HIV-1 remission

Gunst, J. D., Højen, J. F., & Søgaard, O. S. (2020) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000641 · Cited by 22

Single-cell analysis of immune cell transcriptome during HIV-1 infection and therapy

Pollara, J., Khanal, S., Edwards, R. W., Hora, B., Ferrari, G., Haynes, B. F., & Bradley, T. (2022) · BMC Immunology · doi:10.1186/s12865-022-00523-2 · Cited by 21

HIV reservoirs are dominated by genetically younger and clonally enriched proviruses

Kinloch, N. N., Shahid, A., Dong, W., Kirkby, D., Jones, B. R., Beelen, C. J., MacMillan, D., Lee, G. Q., Mota, T. M., Sudderuddin, H., et al. (2023) · mBio · doi:10.1128/mbio.02417-23 · Cited by 21

EZH2 inhibition mitigates HIV immune evasion, reduces reservoir formation, and promotes skewing of CD8+ T cells toward less-exhausted phenotypes

Gramatica, A., Miller, I. G., Ward, A. R., Farzana, K., Kemmer, T. J., Weiler, J., Huynh, T. T., Zumbo, P., Kurland, A. P., Leyre, L., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115652 · Cited by 20

Mycobacterium tuberculosis co-infection is associated with increased surrogate marker of the HIV reservoir

Xun, J., Qi, T., Zou, L., Tang, Q., Shen, Y., Yang, J., Xie, L., Ji, Y., Zhang, R., Liu, L., et al. (2020) · AIDS Research and Therapy · doi:10.1186/s12981-020-00320-0 · Cited by 19

Addressing an HIV cure in LMIC

Ismail, S. D., Pankrac, J., Ndashimye, E., Prodger, J. L., Abrahams, M.-R., Mann, J. F. S., Redd, A. D., & Arts, E. J. (2021) · Retrovirology · doi:10.1186/s12977-021-00565-1 · Cited by 18

Evaluation of HIV-1 reservoir size and broadly neutralizing antibody susceptibility in acute antiretroviral therapy-treated individuals

Moldt, B., Günthard, H. F., Workowski, K., Little, S. J., Eron, J. J., Overton, E. T., Lehmann, C., Rokx, C., Kozal, M. J., Gandhi, R. T., et al. (2021) · AIDS · doi:10.1097/qad.0000000000003088 · Cited by 18

HIV Proviral Burden, Genetic Diversity, and Dynamics in Viremic Controllers Who Subsequently Initiated Suppressive Antiretroviral Therapy

Omondi, F. H., Sudderuddin, H., Shahid, A., Kinloch, N. N., Jones, B. R., Miller, R. L., Tsai, O., MacMillan, D., Piechocka‐Trocha, A., Brockman, M. A., et al. (2021) · mBio · doi:10.1128/mbio.02490-21 · Cited by 18

Towards a Functional Cure of HIV-1: Insight Into the Chromatin Landscape of the Provirus

Janssens, J., Bruggemans, A., Christ, F., & Debyser, Z. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.636642 · Cited by 18

HIV-1 integration sites in CD4+ T cells during primary, chronic, and late presentation of HIV-1 infection

Kok, Y. L., Vongrad, V., Chaudron, S. E., Shilaih, M., Leemann, C., Neumann, K., Kusejko, K., Giallonardo, F. D., Kuster, H., Braun, D. L., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.143940 · Cited by 19

LEDGINs, Inhibitors of the Interaction Between HIV-1 Integrase and LEDGF/p75, Are Potent Antivirals with a Potential to Cure HIV Infection

Debyser, Z., Bruggemans, A., Belle, S. V., Janssens, J., & Christ, F. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-981-16-0267-2_4 · Cited by 18

CCL2: a Chemokine Potentially Promoting Early Seeding of the Latent HIV Reservoir

Packard, T. A., Schwarzer, R., Herzig, E., Rao, D., Luo, X., Egedal, J. H., Hsiao, F., Widera, M., Hultquist, J. F., Grimmett, Z. W., et al. (2022) · mBio · doi:10.1128/mbio.01891-22 · Cited by 17

Substantial uneven proliferation of CD4+ T cells during recovery from acute HIV infection is sufficient to explain the observed expanded clones in the HIV reservoir

Boshier, F. A. T., Reeves, D. B., Duke, E. R., Swan, D. A., Prlic, M., Ojeda, E. F. C., & Schiffer, J. T. (2022) · Journal of Virus Eradication · doi:10.1016/j.jve.2022.100091 · Cited by 17

Natural Killer Cell Receptors and Ligands Are Associated With Markers of HIV-1 Persistence in Chronically Infected ART Suppressed Patients

Ivison, G. T., Vendrame, E., Martínez-Colón, G. J., Ranganath, T., Vergara, R., Zhao, N. Q., Martin, M. P., Bendall, S. C., Carrington, M. N., Cyktor, J. C., et al. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.757846 · Cited by 16

The replication-competent HIV reservoir is a genetically restricted, younger subset of the overall pool of HIV proviruses persisting during therapy, which is highly genetically stable over time

Shahid, A., MacLennan, S., Jones, B. R., Sudderuddin, H., Dang, Z., Cobarrubias, K. D., Duncan, M. C., Kinloch, N. N., Dapp, M. J., Archin, N. M., et al. (2024) · Journal of Virology · doi:10.1128/jvi.01655-23 · Cited by 16

Anti-HIV antibody development up to 1 year after antiretroviral therapy initiation in acute HIV infection

Mitchell, J. L., Pollara, J., Dietze, K. A., Edwards, R. W., Nohara, J., N’guessan, K. F., Zemil, M., Buranapraditkun, S., Takata, H., Li, Y., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci150937 · Cited by 16

Elite and posttreatment controllers, two facets of HIV control

Mastrángelo, A., Banga, R., & Perreau, M. (2022) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000751 · Cited by 16

A targeted reactivation of latent HIV-1 using an activator vector in patient samples from acute infection

Mann, J. F. S., Pankrac, J., Klein, K., McKay, P. F., King, D. F. L., Gibson, R. M., Wijewardhana, C. N., Pawa, R., Meyerowitz, J., Gao, Y., et al. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102853 · Cited by 16

BRD4 modulator ZL0580 and LEDGINs additively block and lock HIV-1 transcription

Pellaers, E., Janssens, J., Wils, L., Denis, A., Bhat, A., Belle, S. V., Feng, D., Christ, F., Zhan, P., & Debyser, Z. (2025) · Nature Communications · doi:10.1038/s41467-025-59398-7 · Cited by 16

Origin of rebound virus in chronically SIV-infected Rhesus monkeys following treatment discontinuation

Liu, P.-T., Keele, B. F., Abbink, P., Mercado, N. B., Liu, J., Bondzie, E. A., Chandrashekar, A., Borducchi, E. N., Hesselgesser, J., Mish, M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19254-2 · Cited by 15

Analysis of the effect of HDAC inhibitors on the formation of the HIV reservoir

Ling, L., Kim, M., Soper, A., Kovarova, M., Spagnuolo, R. A., Begum, N., Kirchherr, J., Archin, N., Battaglia, D., Cleveland, D., et al. (2024) · mBio · doi:10.1128/mbio.01632-24 · Cited by 14

Proviral Turnover During Untreated HIV Infection Is Dynamic and Variable Between Hosts, Impacting Reservoir Composition on ART

Brooks, K., Omondi, F. H., Liang, R. H., Sudderuddin, H., Jones, B. R., Joy, J. B., Brumme, C. J., Hunter, E., & Brumme, Z. L. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.719153 · Cited by 14

Clearance of HIV-1 or SIV reservoirs by promotion of apoptosis and inhibition of autophagy: Targeting intracellular molecules in cure-directed strategies

Chen, M., Li, M., Budai, M. M., Rice, A. P., Kimata, J. T., Mohan, M., & Wang, J. (2022) · Journal of Leukocyte Biology · doi:10.1002/jlb.4mr0222-606 · Cited by 14

Recent advances on anti-HIV chimeric antigen receptor-T-cell treatment to provide sustained HIV remission

Su, H., Mueller, A., & Goldstein, H. (2024) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000858 · Cited by 13

New latency-promoting agents for a block-and-lock functional cure strategy

Pellaers, E., Denis, A., & Debyser, Z. (2024) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000844 · Cited by 13

Interplay between autophagy and apoptosis in human viral pathogenesis

Shao, Q., Liu, T., Hu, B., & Chen, L. (2025) · Virus Research · doi:10.1016/j.virusres.2025.199611 · Cited by 14

Insights into the HIV-1 Latent Reservoir and Strategies to Cure HIV-1 Infection

Bai, R., Lv, S., Wu, H., & Dai, L. (2022) · Disease Markers · doi:10.1155/2022/6952286 · Cited by 13

Characterizing the Relationship Between Neutralization Sensitivity and env Gene Diversity During ART Suppression

Wilson, A., Shakhtour, L., Ward, A. R., Ren, Y., Recarey, M., Stevenson, E. M., Korom, M., Kovacs, C. M., Benko, E., Jones, R. B., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.710327 · Cited by 13

Identification of inducible HIV reservoirs in tonsillar, intestinal and cervical tissue models of HIV latency

Gallego-Cortés, A., Sánchez-Gaona, N., Mancebo-Pérez, C., Ruiz-Isant, O., Benítez-Martínez, A., Landolfi, S., Castellví, J., Pumarola, F., Ortiz, N., Llano, I., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-65288-9 · Cited by 12

Heritability of the HIV-1 reservoir size and decay under long-term suppressive ART

Wan, C., Bachmann, N., Mitov, V., Blanquart, F., Posada-Céspedes, S., Turk, T., Neumann, K., Beerenwinkel, N., Bogojeska, J., Fellay, J., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19198-7 · Cited by 13

Limited impact of fingolimod treatment during the initial weeks of ART in SIV-infected rhesus macaques

Pino, M., Pagliuzza, A., Pampena, M. B., Deléage, C., Viox, E. G., Nguyen, K., Shim, I., Zhang, A., Harper, J. L., Samer, S., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-32698-y · Cited by 12

Dominant CD4+ T cell receptors remain stable throughout antiretroviral therapy-mediated immune restoration in people with HIV

Sponaugle, A. T., Weideman, A. M., Ranek, J. S., Atassi, G., Kuruc, J. D., Adimora, A. A., Archin, N. M., Gay, C. L., Kuritzkes, D. R., Margolis, D. M., et al. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.101268 · Cited by 14

Immunological Correlates of the HIV-1 Replication-Competent Reservoir Size

Ismail, S. D., Riou, C., Joseph, S., Archin, N. M., Margolis, D. M., Perelson, A. S., Cassidy, T., Abrahams, M.-R., Moeser, M., McKinnon, L. R., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab587 · Cited by 12

New Concepts in Therapeutic Manipulation of HIV-1 Transcription and Latency: Latency Reversal versus Latency Prevention

Lewis, C. A., Margolis, D. M., & Browne, E. P. (2023) · Viruses · doi:10.3390/v15081677 · Cited by 11

Assessing advances in three decades of clinical antiretroviral therapy on the HIV-1 reservoir

González-Navarro, I., Urrea, V., Gálvez, C., Puertas, M. C., Morón‐López, S., Puertas, M. C., Grau, E., Mothe, B., Bailón, L., Miranda, C., et al. (2024) · Journal of Clinical Investigation · doi:10.1172/jci183952 · Cited by 11

The role of Tat in HIV latency and reactivation

Margolis, D. M., & Browne, E. P. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1650385 · Cited by 12

HIV-1 latency is established preferentially in minimally activated and non-dividing cells during productive infection of primary CD4 T cells

Soto, P. C., Terry, V. H., Lewinski, M. K., Deshmukh, S., Beliakova‐Bethell, N., & Spina, C. A. (2022) · PLoS ONE · doi:10.1371/journal.pone.0271674 · Cited by 11

Single-Cell Transcriptomics of Mtb/HIV Co-Infection

Kulkarni, S., Endsley, J. J., Lai, Z., Bradley, T., & Sharan, R. (2023) · Cells · doi:10.3390/cells12182295 · Cited by 11

Targeting HIV persistence in the tissue

Pieren, D. K. J., Benítez-Martínez, A., & Genescà, M. (2024) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000836 · Cited by 11

Glutaminolysis of CD4+ T Cells: A Potential Therapeutic Target in Viral Diseases

Xu, Y., Li, M., Lin, M., Cui, D., & Xie, J. (2024) · Journal of Inflammation Research · doi:10.2147/jir.s443482 · Cited by 11

Synthetic gRNA/Cas9 Ribonucleoprotein Inhibits HIV Reactivation and Replication

Khanal, S., Cao, D., Zhang, J., Zhang, Y., Schank, M., Dang, X., Nguyen, L. N. T., Wu, X. Y., Jiang, Y., Ning, S., et al. (2022) · Viruses · doi:10.3390/v14091902 · Cited by 10

HIV proviral genetic diversity, compartmentalization and inferred dynamics in lung and blood during long-term suppressive antiretroviral therapy

Shahid, A., Jones, B. R., Yang, J. S. W., Dong, W. W. Y., Shaipanich, T., Donohoe, K., Brumme, C. J., Joy, J. B., Leung, J. M., & Brumme, Z. L. (2022) · PLoS Pathogens · doi:10.1371/journal.ppat.1010613 · Cited by 10

Clinical trials aimed at HIV cure or remission: new pathways and lessons learned

Schou, M. D., Søgaard, O. S., & Rasmussen, T. A. (2023) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2023.2273919 · Cited by 10

How does the timing of antiretroviral therapy initiation in acute infection affect HIV reservoirs?

Ananworanich, J., Dubé, K., & Chomont, N. (2014) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000122 · Cited by 127

Long-Term Antiretroviral Treatment Initiated at Primary HIV-1 Infection Affects the Size, Composition, and Decay Kinetics of the Reservoir of HIV-1-Infected CD4 T Cells

Buzón, M. J., Martín‐Gayo, E., Pereyra, F., Ouyang, Z., Sun, H., Li, J. Z., Piovoso, M. J., Shaw, A., Dalmau, J., Zangger, N., et al. (2014) · Journal of Virology · doi:10.1128/jvi.01046-14 · Cited by 277

The Effect of Early Treatment on the Latent Reservoir of HIV‐1

Blankson, J. N., Siliciano, J. D., & Siliciano, R. F. (2005) · The Journal of Infectious Diseases · doi:10.1086/428783 · Cited by 6

Establishment of latent HIV-1 reservoirs: what do we really know?

Vanhamel, J., Bruggemans, A., & Debyser, Z. (2019) · Journal of Virus Eradication · doi:10.1016/s2055-6640(20)30275-2 · Cited by 125

HIV-1 DNA and the HIV-1 Viral Reservoir

McBride, K. L. (2022) · UNSWorks (UNSW Sydney) · doi:10.26190/unsworks/16312